The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The MILO (MEK inhibitor in low-grade serous ovarian cancer)/ENGOT-ov11 study: A multinational, randomized, open-label phase 3 study of binimetinib (MEK162) versus physician’s choice chemotherapy in patients with recurrent or persistent low-grade serous carcinomas of the ovary, fallopian tube, or primary peritoneum.
 
Bradley J. Monk
No Relationships to Disclose
 
Rachel N. Grisham
Consulting or Advisory Role - Amgen
Research Funding - Medivation
 
Christian Marth
No Relationships to Disclose
 
Susana N. Banerjee
No Relationships to Disclose
 
Felix Hilpert
Honoraria - Amgen; AstraZeneca; MSD; Roche Pharma AG
Consulting or Advisory Role - Amgen; AstraZeneca; MSD; Roche Pharma AG
Travel, Accommodations, Expenses - AstraZeneca; Roche Pharma AG
 
Robert L. Coleman
Honoraria - NCCN
Consulting or Advisory Role - Clovis Oncology; Esperance Pharmaceuticals; Genentech/Roche
Research Funding - Amgen; Array BioPharma; AstraZeneca/MedImmune; Clovis Oncology; Esperance Pharmaceuticals; Johnson & Johnson; Merrimack; OncoMed
Travel, Accommodations, Expenses - Amgen; Array BioPharma; AstraZeneca/MedImmune; Gradalis; Merck; Merrimack; Millennium
 
Eric Pujade-Lauraine
Honoraria - AstraZeneca; Roche Pharma AG
 
Sandro Pignata
Honoraria - AstraZeneca; Roche Pharma AG
Consulting or Advisory Role - AstraZeneca; Roche Pharma AG
Research Funding - AstraZeneca; Janssen; Roche Pharma AG
 
Mansoor Raza Mirza
No Relationships to Disclose
 
Amit M. Oza
Consulting or Advisory Role - Amgen; Clovis Oncology; Verastem
Research Funding - AstraZeneca; Immunogen; Immunovaccine; Merck; Roche
Travel, Accommodations, Expenses - AstraZeneca; Roche
 
Josep M. del Campo
Speakers' Bureau - Roche Pharma AG
 
Martin Klaus Oehler
No Relationships to Disclose
 
Adam James
Employment - Array BioPharma
Stock and Other Ownership Interests - Array BioPharma
 
Janna Christy-Bittel
Employment - Array BioPharma
Stock and Other Ownership Interests - Array BioPharma
 
Emma Barrett
Employment - Array BioPharma
Stock and Other Ownership Interests - Array BioPharma
 
Adam P. Boyd
Employment - Array BioPharma
Stock and Other Ownership Interests - Array BioPharma
 
Ignace Vergote
No Relationships to Disclose